Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic Policy Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law previous34567next Taking a Stand on USPTO Request for Continued Examination (RCE) Policy 31 January 2013 PharmaPatents Next week (February 4, 2013) is the deadline for submitting comments in response to the USPTO’s request for feedback on Request for Continued Examination (RCE) practice.... The Patent Term Adjustment Pendulum Swings the Other Way 29 January 2013 PharmaPatents On January 28, 2012, Judge Brinkema of the U.S. District Court for the Eastern District of Virginia issued a decision in a different Exelixis v. Kappos Patent Term... Maximizing Patent Term Adjustment Under Exelixis 24 January 2013 PharmaPatents A number of Patent Term Adjustment (PTA) cases have been filed in the U.S. District Court for the Eastern District of Virginia since the November 1, 2012 decision... USPTO Announces New, Higher USPTO Patent Fees 22 January 2013 PharmaPatents The USPTO has published the new patent fee structure that it is implementing pursuant to its fee-setting authority under the Leahy-Smith America Invents Act (AIA).... The Patent Prosecution Highway Pothole for Pharmaceutical Patents 17 January 2013 PharmaPatents The USPTO promotes the Patent Prosecution Highway (PPH) as a way to “fast-track” a U.S. patent application when a corresponding foreign application has been allowed,... Countdown to the Ides of March 15 January 2013 PharmaPatents As of today, we are two months from March 15, 2013–the last day to secure an effective filing date under the current “first to invent” patent system. While we still... Supreme Court to Hear AndroGel Reverse Payment Case 10 January 2013 PharmaPatents The Supreme Court granted certiorari in Federal Trade Commission v. Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to... House, Senate Pass Changes to America Invents Act and Patent Term Adjustment 08 January 2013 PharmaPatents The Senate has passed a modified version of HR 6621, which focuses on changes “[t]o correct and improve certain provisions of the Leahy-Smith America Invents Act”... Congress Approves Patent "Corrections and Improvements" Act, President's Signature Expected Shortly 04 January 2013 Legal News Alert: Intellectual Property On January 1, 2013, a bill (H.R. 6621) cleared both houses of Congress to “correct and improve certain provisions” in the Leahy-Smith America Invents Act of 2011... USPTO Appeals Exelixis Patent Term Adjustment Decision 04 January 2013 PharmaPatents As expected, the USPTO has filed a Notice of Appeal in the Exelixis patent term adjustment (PTA) case. As I summarized in this article, in a decision issued November... previous34567next Related 1 2 3
Taking a Stand on USPTO Request for Continued Examination (RCE) Policy 31 January 2013 PharmaPatents Next week (February 4, 2013) is the deadline for submitting comments in response to the USPTO’s request for feedback on Request for Continued Examination (RCE) practice....
The Patent Term Adjustment Pendulum Swings the Other Way 29 January 2013 PharmaPatents On January 28, 2012, Judge Brinkema of the U.S. District Court for the Eastern District of Virginia issued a decision in a different Exelixis v. Kappos Patent Term...
Maximizing Patent Term Adjustment Under Exelixis 24 January 2013 PharmaPatents A number of Patent Term Adjustment (PTA) cases have been filed in the U.S. District Court for the Eastern District of Virginia since the November 1, 2012 decision...
USPTO Announces New, Higher USPTO Patent Fees 22 January 2013 PharmaPatents The USPTO has published the new patent fee structure that it is implementing pursuant to its fee-setting authority under the Leahy-Smith America Invents Act (AIA)....
The Patent Prosecution Highway Pothole for Pharmaceutical Patents 17 January 2013 PharmaPatents The USPTO promotes the Patent Prosecution Highway (PPH) as a way to “fast-track” a U.S. patent application when a corresponding foreign application has been allowed,...
Countdown to the Ides of March 15 January 2013 PharmaPatents As of today, we are two months from March 15, 2013–the last day to secure an effective filing date under the current “first to invent” patent system. While we still...
Supreme Court to Hear AndroGel Reverse Payment Case 10 January 2013 PharmaPatents The Supreme Court granted certiorari in Federal Trade Commission v. Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to...
House, Senate Pass Changes to America Invents Act and Patent Term Adjustment 08 January 2013 PharmaPatents The Senate has passed a modified version of HR 6621, which focuses on changes “[t]o correct and improve certain provisions of the Leahy-Smith America Invents Act”...
Congress Approves Patent "Corrections and Improvements" Act, President's Signature Expected Shortly 04 January 2013 Legal News Alert: Intellectual Property On January 1, 2013, a bill (H.R. 6621) cleared both houses of Congress to “correct and improve certain provisions” in the Leahy-Smith America Invents Act of 2011...
USPTO Appeals Exelixis Patent Term Adjustment Decision 04 January 2013 PharmaPatents As expected, the USPTO has filed a Notice of Appeal in the Exelixis patent term adjustment (PTA) case. As I summarized in this article, in a decision issued November...